Evidence map›Paper›PMID 26645990›Full record

ArticleInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2016

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.

Nicoletta Colombo, Carien Creutzberg, Frederic Amant, Tjalling Bosse, Antonio González-Martín, Jonathan Ledermann, Christian Marth, Remi Nout, Denis Querleu, Mansoor Raza Mirza and 2 more

4 registry-linked trialsAbstract readConsensus Statement
In one paragraph

Article in International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 418 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
418citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02826291 completednot on this map

Sentinel Lymph Node Mapping in Endometrial Cancer Patients Combined With One-step Nucleic Acid Amplification (OSNA)

TypeobservationalSponsorCharles University, Czech RepublicRan2016 to 2018Enrolled58ConditionsEndometrial CancerArmsRD-100i, OSNA
NCT03621904 recruitingnot on this mapstarted 2022, after this paper: background citation

PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer

Typeobservational_patient_registrySponsorRadboud University Medical CenterRan2022 to 2027Enrolled150ConditionsEndometrial Cancer Stage III, Endometrial Cancer Stage IV, Endometrial Cancer RecurrentArmsHormonal Antineoplastics
NCT04184154 completednot on this mapstarted 2017, after this paper: background citation

Vaginal Dilatators and Moisturizers Use and Sexual Quality of Life of Patients With Gynecologic Cancer Treated With Brachytherapy.

TypeobservationalSponsorInstitut du Cancer de Montpellier - Val d'AurelleRan2017 to 2017Enrolled167ConditionsPelvic Cancer, Cervical CancerArmsQuestionnaires
NCT06102252 nacompletednot on this mapstarted 2024, after this paper: background citation

Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma

TypeinterventionalSponsorSohag UniversityRan2024 to 2025Enrolled60ConditionsEndometrial CarcinomaArmsPaclitaxel/epirubcin/carboplatin, Paclitaxel/carboplatin
3 · Its place in the literature

Who cites it

418 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Biology · 2026
    Article
  20. Article

358 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nicoletta Colombo*Division of Medical Gynecologic Oncology, European Institute of Oncology and University of Milan-Bicocca, Milan, Italy; †Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands; ‡Department of Gynecological Oncology, University Hospital Leuven, Leuven, Belgium and Center for Gynecological Oncology Amsterdam (CGOA), Antoni van Leeuwenhoek, Amsterdam, The Netherlands; §Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands; ∥Medical Oncology Department, GEICO and MD Anderson Cancer Center, Madrid, Spain; ¶Department of Oncology and Cancer Trials, UCL Cancer Institute, London, United Kingdom; #Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria; **Department of Radiotherapy, Leiden University Medical Center, Leiden, The Netherlands; ††Department of Surgery, Institut Bergonié, Bordeaux, France and Gynecology and Obstetrics Department, McGill University Health Centre, Montreal, Quebec, Canada; ‡‡Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; and §§Department of Medical Oncology, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.
Carien Creutzberg
Frederic Amant
Tjalling Bosse
Antonio González-Martín
Jonathan Ledermann
Christian Marth
Remi Nout
Denis Querleu
Mansoor Raza Mirza
Cristiana Sessa
ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically-relevant questions about endometrial cancer relating to the following four areas: prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article.

Indexed as

Practice Guidelines as TopicEndometrial NeoplasmsFemaleFollow-Up StudiesHumansMedical OncologySocieties, Medical

Identifiers

PMID26645990
PMCPMC4679344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.